Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells

D Lo, LC Burkly, G Widera, C Cowing, RA Flavell… - Cell, 1988 - cell.com
D Lo, LC Burkly, G Widera, C Cowing, RA Flavell, RD Palmiter, RL Brinster
Cell, 1988cell.com
Insulin-dependent diabetes is caused by the loss of insulin-producing beta cells in
pancreatic islets. It has been proposed that aberrant expression of Class II Major
Histocompatibility Complex (MHC) molecules on beta cells stimulates an autoimmune attack
against beta cell antigens. To test this hypothesis, we generated transgenic mice that
express Class II MHC molecules (E,, d/Ellb, or I-Eb) on beta cells. Diabetes was found in
100% of transgenic progeny from three expressing transgenic mouse lines, but without …
Summary
Insulin-dependent diabetes is caused by the loss of insulin-producing beta cells in pancreatic islets. It has been proposed that aberrant expression of Class II Major Histocompatibility Complex (MHC) molecules on beta cells stimulates an autoimmune attack against beta cell antigens. To test this hypothesis, we generated transgenic mice that express Class II MHC molecules (E,, d/Ellb, or I-Eb) on beta cells. Diabetes was found in 100% of transgenic progeny from three expressing transgenic mouse lines, but without evidence for lymphocytic infiltrates. Furthermore, T lymphocytes appeared to be tolerant to the transgene I-Eb molecule, despite the absence of expression of I-Eb in the thymus or any other lymphoid tissue. The results suggest that novel expression of Class II MHC molecules on nonlymphoid cells is by itself insufficient to initiate autoimmune responses against tissuespecific antigens.
cell.com